Zydis (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Zydis" in English language version.

refsWebsite

Global rank English rank

3^rd place

1^st place

518^th place

331^st place

4^th place

low place

low place

2^nd place

121^st place

142^nd place

academia.edu

Rajendra Awasthi; et al. (2013). "Fast Disintegrating Drug Delivery Systems: A Review with Special Emphasis on Fast Disintegrating Tablets". Journal of Chemotherapy and Drug Delivery, 05/2013. Retrieved 2014-08-30.

Al-Achi, Antoine; Gupta, Mail Ram; Stagner, William Craig (2013). "Formulation development concepts". Integrated Pharmaceutics: Applied Preformulation, Product Design, and Regulatory Science. John Wiley & Sons. p. 164. ISBN 9781118356715. Retrieved 2014-09-01.
Rathbone, Michael J.; Hadgraft, Jonathan; Roberts, Michael S. (2002). "The Zydis Oral Fast-Dissolving Dosage Form". Modified-Release Drug Delivery Technology. CRC Press. p. 191. ISBN 9780824708696. Retrieved 2014-08-26.
Allen, Lloyd (2014). "Tablets". Ansel's Pharmaceutical Dosage Forms and Drug Delivery Systems. Lippincott Williams & Wilkins. p. 267. ISBN 9781469871943. Retrieved 2014-08-30.
Wen, Hong; Park, Kinam (2011). "Patented Technologies". Oral Controlled Release Formulation Design and Drug Delivery: Theory to Practice. John Wiley & Sons. p. 161. ISBN 9781118060322. Retrieved 2014-09-01.
Jorgensen, Lene; Nielson, Hanne Morck (2009). "Comparison of advantages and disadvantages of different fast dissolving tablet technologies". Delivery Technologies for Biopharmaceuticals: Peptides, Proteins, Nucleic Acids and Vaccines. John Wiley & Sons. p. 399. ISBN 9780470688403. Retrieved 2014-09-01.

Ved Parkash; et al. (2011). "Fast disintegrating tablets: Opportunity in drug delivery system". Journal of Advanced Pharmaceutical Technology & Research. 2 (4): 223–35. doi:10.4103/2231-4040.90877. PMC 3255350. PMID 22247889.

Amipara; et al. (2013). "Oral disintirating tablet of antihypertensive drug". Journal of Drug Delivery & Therapeutics; 2013, 3(1). Archived from the original on 2014-09-03. Retrieved 2014-08-30.

Ved Parkash; et al. (2011). "Fast disintegrating tablets: Opportunity in drug delivery system". Journal of Advanced Pharmaceutical Technology & Research. 2 (4): 223–35. doi:10.4103/2231-4040.90877. PMC 3255350. PMID 22247889.

Ved Parkash; et al. (2011). "Fast disintegrating tablets: Opportunity in drug delivery system". Journal of Advanced Pharmaceutical Technology & Research. 2 (4): 223–35. doi:10.4103/2231-4040.90877. PMC 3255350. PMID 22247889.

"Pepcidine launch in Sweden". The Pharma Letter. 1993-08-23. Retrieved 2014-08-30. A new formulation of Pepcidine (famotidine), utilizing R P Scherer's Zydis fast-dissolving dosage form technology, has been launched in Sweden by Merck, Sharp & Dohme, and will be rolled-out initially in other Scandinavian countries within a short time. The new formulation, known generally as Pepcidine RPD, and in Sweden as Pepcidin Rapitab, is the first H2 antagonist to dissolve in the mouth without water.

"Scherer announces launch of another product utilizing its Zydis technology". PR Newswire Association LLC. 1993-11-09. Archived from the original on 2014-08-30. Retrieved 2014-08-30.
"Scherer Announces U.S. Marketing Clearance for the First Prescription Product Using Zydis(R) Technology". PR Newswire Association LLC. 1996-12-23. Archived from the original on 2014-08-30. Retrieved 2014-08-30.
Amipara; et al. (2013). "Oral disintirating tablet of antihypertensive drug". Journal of Drug Delivery & Therapeutics; 2013, 3(1). Archived from the original on 2014-09-03. Retrieved 2014-08-30.